About the Initiative

Rethinking Blood Use

Blood & Beyond is a multi-stakeholder initiative developed and funded by Celgene, now part of Bristol Myers Squibb, involving experts from the fields of haematology and blood management, nursing, patient advocacy, health economics and hospital management.

The aim of the initiative is to raise awareness of the impact of blood transfusion on patients, support networks, healthcare systems and society at large; with the overarching goal to help advance policies and practices that improve patient outcomes by optimising blood management and supporting innovation across Europe.

Launch Event

The Blood and Beyond initiative hosted an online webinar on Thursday, March 26, 2020, to officially launch the initiative and report.


Recent developments around blood transfusions and optimal blood management across Europe.